TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. 2001

H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
Department of Immunology, Genentech Inc. South San Francisco, CA 94080, USA.

Interactions of the tumor necrosis factor superfamily members B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) with their receptors-transmembrane activator and CAML interactor (TACI) and B cell maturation molecule (BCMA)-on B cells play an important role in the humoral immune response. Whereas BCMA is restricted to B cells, TACI is also expressed on activated T cells; we show here that TACI-Fc blocks the activation of T cells in vitro and inhibits antigen-specific T cell activation and priming in vivo. In a mouse model for rheumatoid arthritis (RA), an autoimmune disease that involves both B and T cell components, TACI-Fc treatment substantially inhibited inflammation, bone and cartilage destruction and disease development. Thus, BLyS and/or APRIL are important not only for B cell function but for T cell-mediated immune responses. Inhibition of these ligands might have therapeutic benefits for autoimmune diseases, such as RA, that involve both B and T cells.

UI MeSH Term Description Entries
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
January 1993, Autoimmunity,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
March 2011, European journal of pharmacology,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
January 2020, Journal of translational autoimmunity,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
August 2022, Science immunology,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
February 1993, European journal of immunology,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
August 1985, Journal of immunology (Baltimore, Md. : 1950),
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
May 2000, Scandinavian journal of immunology,
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
April 2002, Journal of immunology (Baltimore, Md. : 1950),
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
August 1999, Journal of immunology (Baltimore, Md. : 1950),
H Wang, and S A Marsters, and T Baker, and B Chan, and W P Lee, and L Fu, and D Tumas, and M Yan, and V M Dixit, and A Ashkenazi, and I S Grewal
August 1994, The Journal of experimental medicine,
Copied contents to your clipboard!